Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Initial specialist validation of clinical decision support recommendations from a machine learning-enabled digital cognitive assessment.

Frontiers in neurology·2026
Same author

Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort.

Alzheimer's research & therapy·2026
Same author

System changes to empower primary care in Alzheimer's disease detection and care.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Defining neurocognitive constructs underlying visual attention in mild cognitive impairment and dementia using digital assessment technology.

Journal of Alzheimer's disease : JAD·2026
Same author

Psychometric modeling of Boston process approach data for dementia prediction in the Framingham Heart Study.

Journal of the International Neuropsychological Society : JINS·2026
Same author

Streamlining Eligibility Assessment for Alzheimer's Disease-Modifying Therapies: Prediction of MMSE Scores Using the Digital Clock and Recall.

medRxiv : the preprint server for health sciences·2026

相关实验视频

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

临床表现 临床表现

Daniel J Schulman1, David J Libon2,3, Ali Jannati1

  • 1Linus Health, Boston, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

这项研究使用数字认知评估工具将参与者分为认知不受损,痴呆症和两种轻度认知障碍 (MCI) 亚型. 7分钟的数字评估显示,在阿尔茨海默病临床试验中确定MCI亚型具有前途.

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

相关实验视频

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 数字健康数字健康

背景情况:

  • 阿尔茨海默病 (AD) 临床试验面临着高的屏幕失败率.
  • 包括数字认知评估 (DAC) 在内的数字生物标志物正在开发中,以改善参与者选择.
  • 在Aphelia-001研究中,使用DAC和基于血液的生物标志物来减少AD试验中的查失败.

研究的目的:

  • 开发和验证一种方法,使用DAC指标将参与者分为认知正常 (CU),轻度认知障碍 (MCI) 和痴呆症队列.
  • 探索DAC在区分MCI的亚型中的实用性.
  • 使用半监督方法,用更大的未标记数据集来增强有限的标记数据.

主要方法:

  • 结合了Aphelia-001数据 (n=1189) 与具有确定的诊断的记忆诊所数据集 (n=106).
  • 将修改后的有限混合物集群模型应用于DAC分数,以识别3-5个集群 (CU,痴呆症,1-3MCI).
  • 通过专家共识选择了最终的4个集群模型,通过年龄,教育,时钟和回忆 (DCR) 和迷你心理状态考试 (MMSE) 的分数进行验证.

主要成果:

  • 选择了一个4个集群模型,确定了不同的CU,痴呆症和两个MCI亚型 (记忆障碍和混合/dysexecutive).
  • 群体之间观察到年龄,教育,DCR和MMSE得分的显著差异,与假设的认知障碍水平保持一致.
  • 与混合/不执行MCI集群相比,大赦MCI集群在DCR延迟自由回忆方面得分明显较低.

结论:

  • 七分钟的DAC自动评估可以有效地区分认知完整的个体,痴呆症患者和两个不同的MCI亚型.
  • 这个数字工具显示了在阿尔茨海默病临床试验中改善诊断准确度和参与者分层的潜力.
  • 需要进一步验证,但DAC显示出作为可扩展和高效的认知评估方法的承诺.